Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Esaxerenone (CS-3150) in Essential Hypertension
jRCT2080221876Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of esaxerenone in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd. Started Aug 2012; status: completed.
02
Drugs
esaxerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080221876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221876.